Get the Stockscreener App
618.49
4.51%
26.67
Medpace Holdings Inc stock is traded at $618.49, with a volume of 543.90K.
It is up +4.51% in the last 24 hours and up +2.20% over the past month.
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.
See More
Previous Close:
$591.82
Open:
$597.13
24h Volume:
543.90K
Relative Volume:
1.75
Market Cap:
$17.42B
Revenue:
$2.23B
Net Income/Loss:
$418.30M
P/E Ratio:
45.99
EPS:
13.4469
Net Cash Flow:
$579.82M
1W Performance:
+5.59%
1M Performance:
+2.20%
6M Performance:
+109.74%
1Y Performance:
+83.12%
1-Day Range:
$593.44
$620.79
1-Week Range:
$575.00
$620.79
52-Week Range:
$250.05
$625.00
Medpace Holdings Inc Stock (MEDP) Company Profile
Name
Medpace Holdings Inc
Sector
Industry
Phone
(513) 579-9911
Address
5375 MEDPACE WAY, CINCINNATI, OH
Compare MEDP with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MEDP
Medpace Holdings Inc
|
618.49 | 16.67B | 2.23B | 418.30M | 579.82M | 13.45 |
|
TMO
Thermo Fisher Scientific Inc
|
586.07 | 220.72B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
226.98 | 160.62B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
752.14 | 57.96B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
153.60 | 42.88B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
228.18 | 38.30B | 15.90B | 1.28B | 2.21B | 7.2842 |
Medpace Holdings Inc Stock (MEDP) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-13-25 | Initiated | BMO Capital Markets | Market Perform |
| Oct-02-25 | Downgrade | Barclays | Equal Weight → Underweight |
| Sep-03-25 | Downgrade | Rothschild & Co Redburn | Buy → Neutral |
| Jul-29-25 | Downgrade | UBS | Neutral → Sell |
| Jul-23-25 | Downgrade | TD Cowen | Hold → Sell |
| Jun-24-25 | Initiated | Barclays | Equal Weight |
| Apr-22-25 | Downgrade | William Blair | Outperform → Mkt Perform |
| Apr-14-25 | Downgrade | TD Cowen | Buy → Hold |
| Mar-24-25 | Initiated | Leerink Partners | Market Perform |
| Oct-23-24 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Oct-14-24 | Initiated | Redburn Atlantic | Buy |
| Sep-27-24 | Downgrade | UBS | Buy → Neutral |
| Sep-25-24 | Downgrade | Jefferies | Buy → Hold |
| Aug-01-24 | Initiated | Truist | Hold |
| May-29-24 | Initiated | TD Cowen | Buy |
| May-28-24 | Initiated | Mizuho | Buy |
| Apr-23-24 | Upgrade | Jefferies | Hold → Buy |
| Mar-18-24 | Initiated | Deutsche Bank | Hold |
| Feb-15-24 | Upgrade | UBS | Neutral → Buy |
| Oct-24-23 | Upgrade | Robert W. Baird | Neutral → Outperform |
| May-08-23 | Upgrade | Guggenheim | Neutral → Buy |
| Oct-27-22 | Upgrade | UBS | Sell → Neutral |
| Sep-07-22 | Initiated | UBS | Sell |
| May-24-22 | Initiated | Guggenheim | Neutral |
| Aug-05-21 | Resumed | Credit Suisse | Outperform |
| Oct-02-20 | Upgrade | Truist | Hold → Buy |
| Jun-08-20 | Upgrade | Robert W. Baird | Underperform → Neutral |
| May-13-20 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Apr-30-20 | Upgrade | SunTrust | Sell → Hold |
| Apr-20-20 | Downgrade | Robert W. Baird | Neutral → Underperform |
| Mar-17-20 | Downgrade | SunTrust | Hold → Sell |
| Jan-27-20 | Downgrade | SunTrust | Buy → Hold |
| Oct-31-18 | Upgrade | SunTrust | Hold → Buy |
| Sep-17-18 | Initiated | SunTrust | Hold |
| Jul-31-18 | Upgrade | William Blair | Mkt Perform → Outperform |
| Nov-01-17 | Downgrade | William Blair | Outperform → Mkt Perform |
| Sep-29-17 | Initiated | Raymond James | Mkt Perform |
| Jul-10-17 | Downgrade | KeyBanc Capital Mkts | Overweight → Sector Weight |
View All
Medpace Holdings Inc Stock (MEDP) Latest News
BrightSpring Health Services, 10x Genomics, QuidelOrtho, Medpace, and Fortrea Shares Are Soaring, What You Need To Know - Yahoo Finance
Medpace Holdings, Inc. (MEDP) Stock Forecasts - Yahoo Finance
Don't Ignore The Insider Selling In Medpace Holdings - 富途牛牛
Is Medpace Holdings Inc a good long term investmentVolatility Adjusted Trading & Big Gains Small Capital - earlytimes.in
Assessing Medpace (MEDP) Valuation Following Recent Insider Stock Sales by CEO and Director - Yahoo Finance
Medpace Holdings Inc. (MEDP) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Medpace Holdings, Inc. (MEDP) Stock forecasts - Yahoo Finance UK
CFO Brady Files To Sell 3,000 Of Medpace Holdings Inc [MEDP] - TradingView
August J Troendle Implements A Sell Strategy: Offloads $18.38M In Medpace Hldgs Stock - Benzinga
Why retail investors pile into Medpace Holdings Inc. stockEntry Point & Safe Entry Momentum Stock Tips - newser.com
Medpace (MEDP) Surged Following Better-Than-Expected Results - Insider Monkey
Medpace Holdings Inc Stock Analysis and ForecastReal Estate Investment Trusts & Free Wealth Planning Blueprints - earlytimes.in
Medpace Holdings CEO Sells Over $18 Million in Company Stock - TradingView
Chmn Troendle Sells 31,053 ($18.4M) Of Medpace Holdings Inc [MEDP] - TradingView
Published on: 2025-11-19 21:19:07 - newser.com
Will Medpace Holdings Inc. stock attract more institutional investorsJuly 2025 Fed Impact & High Yield Equity Trading Tips - newser.com
Is Medpace Holdings Inc. stock bottoming outWeekly Gains Summary & Step-by-Step Swing Trade Plans - newser.com
Can Medpace Holdings Inc. stock hit analyst price targetsMarket Activity Report & Smart Swing Trading Techniques - newser.com
Why Medpace Holdings Inc. (01P) stock stays on buy listsWeekly Investment Recap & Entry Point Confirmation Alerts - newser.com
What data driven models say about Medpace Holdings Inc.’s futureJuly 2025 Decliners & Reliable Volume Spike Trade Alerts - newser.com
Medpace Retail Trader Optimism Abounds As Stock Poised For Best Day Ever On Q2 Beat, Outlook - MSN
Does Medpace Holdings Inc. (01P) stock trade below intrinsic valueJuly 2025 Drop Watch & Advanced Technical Signal Analysis - newser.com
How to monitor Medpace Holdings Inc. with trend dashboardsPortfolio Value Summary & AI Forecasted Stock Moves - newser.com
CEO Of Medpace Hldgs Sold $12.35M In Stock - Benzinga
Options Movement At Medpace Hldgs: Robert O Kraft Exercises Worth $3.45M - Benzinga
Medpace Holdings Insider Sold Shares Worth $3,830,453, According to a Recent SEC Filing - MarketScreener
Medpace Holdings CEO Sells Over $12 Million in Company Stock - TradingView
Chmn Troendle Sells 20,794 ($12.4M) Of Medpace Holdings Inc [MEDP] - TradingView
[Form 4] Medpace Holdings, Inc. Insider Trading Activity - Stock Titan
Medpace (MEDP) is an Incredible Growth Stock: 3 Reasons Why - sharewise.com
Medpace: From Q3 25 success to future horizons - MarketScreener
Medpace Holdings Inc Stock (MEDP) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.35%
1.41%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):